Egypt Pharmaceuticals & Healthcare Report Q1 2015 - New Report Available

From: Fast Market Research, Inc.
Published: Fri Feb 06 2015

Recent developments have led us to hold a more positive outlook for Egypt's pharmaceutical and healthcare market s . An increased healthcare budget for 2015, combined with the government's efforts at developing the local manufacturing industry and combating medicine shortages and counterfeit drugs are all positive developments. We expect Egypt's relative political stabilit y and positive economic outlook to further increa se interest from foreign pharmaceutical companies .

Headline Expenditure Projections

* Pharmaceuticals: EGP16.55bn (USD2.41bn) in 2013 to EGP17.66bn (USD2.49bn) in 2014; +6.7% in local currency terms and 3.4% in US dollar terms. Forecast broadly in line with Q414.
* Healthcare: EGP84.76bn (USD12.33bn) in 2013 to EGP95.80bn (USD13.49bn) in 2014; +13.0% in local currency terms and 9.4% in US dollar terms. Forecast unchanged from Q414.

Full Report Details at

Risk/Reward Index: An improving economic and political outlook for Egypt means that the country remains a moderately attractive commercial opportunity for multinational pharmaceutical companies. In our Q115 Pharmaceutical Risk/Reward Index (RRI) Egypt's score of 41.9 out of 100 is lower than the Q414 score of 46.4. Its status in the Middle East and Africa region has not improved, and the country has dropped to 13 th position, down from last quarter when it was the 12 th most attractive market in the region.

Key Trends And Developments

* In December 2014, the Export Council of Medical Industries began a new plan for the expansion of Egyptian exports to a number of African, Asian and European markets in order to make up for the loss in export trade to Libya, Iraq, Syria and Yemen - due to the political situations in those countries. The Export Council's promotional visit to Romania resulted in the signing of an agreement to export Egyptian medicines and medical supplies to government hospitals in Romania. Mohi Hafez, a member of the Export Council, confirmed that the Export Council is planning to...

The Egypt Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Egypt Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Egypt pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Egypt, to test other views - a key input for successful budgeting and strategic business planning in the Egyptian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Vietnam Pharmaceuticals & Healthcare Report Q1 2015
- United Arab Emirates Pharmaceuticals & Healthcare Report Q1 2015
- Malaysia Pharmaceuticals & Healthcare Report Q1 2015
- Peru Pharmaceuticals & Healthcare Report Q1 2015
- Lithuania Pharmaceuticals & Healthcare Report Q1 2015
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »